利凡诺联合米非司酮用于瘢痕子宫中期妊娠引产34例

目的研究利凡诺联合米非司酮用于瘢痕子宫中期妊娠引产的疗效和安全性。方法回顾性分析2011年3月至2014年3月66例瘢痕子宫中期妊娠引产患者的临床资料,其中利凡诺治疗32例（对照组）,利凡诺联合米非司酮治疗34例（治疗组）,比较两组患者的疗效和安全性。结果治疗组宫缩发动时间、胎儿胎盘娩出时间、出血量和胎盘残留率均显著低于对照组（P〈0.01）;两组软产道裂伤率和引产成功率比较,差异无统计学意义（P〉0.05）。结论利凡诺联合米非司酮用于瘢痕子宫中期妊娠引产的疗效确切,安全性好,值得临床推广。

Clinical Study of Rivanol Combined with Mifepristone for Treating Induced Abortion in Scar Uterine Midtrimester Pregnancy in 34 Cases

Objective To investigate the effect of rivanol combined with mifepristone for treating induced abortion in scar uterine midtrimester pregnancy. Methods The clinical data of 66 patients with induced abortion in the scar uterine midtrimester pregnancy in our hospital from March 2011 to March 2014 were retrospectively analyzed. Among them, 32 cases were treated by rivanol（ control group） and 34 cases were treated by rivanol combined with mifepristone（ treatment group）. Then the effects and security were compared between the two groups. Results The initial time of uterine contraction, delivery time of fetus and placenta, bleeding volume and placental residual rate in the treatment group were significantly lower than those in the control group（ P〈0. 01）; the laceration rate of soft birth canal and the success rate of induced abortion had no statistically significant difference between the two groups（ P〉0.05）.Conclusion The combination of rivanol with mifepristone has definite effect and good safety for induced abortion in scar uterine mistrimester pregnancy,and deserves to be clinically promoted.